Combination pharmaceutical therapies for obesity.


Journal Article

The anti-obesity medications available at present achieve a rather modest degree of weight loss that falls below the expectations of clinicians as well as consumers. Several combination drug therapies are in development with the aim of achieving better results that would be clinically more meaningful in the reduction of obesity-related health risks. This paper discusses the pros and cons of combination therapies, and the ongoing research in this area.

Full Text

Cited Authors

  • Gadde, KM; Allison, DB

Published Date

  • April 2009

Published In

Volume / Issue

  • 10 / 6

Start / End Page

  • 921 - 925

PubMed ID

  • 19351275

Pubmed Central ID

  • 19351275

Electronic International Standard Serial Number (EISSN)

  • 1744-7666

Digital Object Identifier (DOI)

  • 10.1517/14656560902824152


  • eng

Conference Location

  • England